Tyrosine receptor kinase B silencing inhibits anoikis-resistance and improves anticancer efficiency of sorafenib in human renal cancer cells

Peng Zhang(Wuhan University), Yifei Xing(Union Hospital)
International Journal of Oncology
January 25, 2016
Cited by 32


Related Papers